New Zealand Trial PSI-7977 and RBV With and Without PEG-IFN/recruiting link

[Guest guest]

New Zealand Trial PSI-7977 and RBV With and Without PEG-IFN/recruiting link

Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3This study is currently recruiting participants. Contacts and Locations Please refer to this study by its ClinicalTrials.gov identifier: NCT01260350ContactsContact: Fiona Mackay, BSc 6498171460 fiona.mackay@... Contact: Sorensen 609-613-4100 rsorensen@... LocationsNew Zealand Auckland Clinical Studies Ltd. Recruiting Auckland, New Zealand Contact: Ed Gane, Assoc. Prof

Principal Investigator: Ed Gane, Assoc. Prof Christchurch Clinical Studies Trust Recruiting Christchurch, New Zealand Contact: Stedman, MD Principal Investigator: Stedman, MD

http://Hepatitis Cnewdrugs.blogspot.com/2011/04/new-zealand-trial-psi-7977-and-rbv-with.html